Grifols (GRFS) Deferred Taxes (2009 - 2011)
Grifols (GRFS) posted Deferred Taxes of -$18.2 million for Q4 2011, down 186.23% quarter-over-quarter from $21.1 million in Q4 2010, and down 186.23% year-on-year from $21.1 million in Q4 2010.
Grifols (GRFS) Deferred Taxes (2009 - 2011) Analysis & Trends
Grifols (GRFS) has reported Deferred Taxes for 2 consecutive years, with -$18.2 million the latest figure, recorded in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.48 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 159.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 137.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -315.00 Mn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | -176.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 179.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | -12.00 Mn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | -18.21 Mn |
| Dec 31, 2010 | 21.11 Mn |
| Dec 31, 2009 | 13.04 Mn |